Gotham Asset Management LLC grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 12.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 472,756 shares of the pharmacy operator's stock after acquiring an additional 52,754 shares during the period. Gotham Asset Management LLC owned about 0.05% of Walgreens Boots Alliance worth $4,411,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Franklin Resources Inc. increased its position in shares of Walgreens Boots Alliance by 54.4% in the 3rd quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator's stock worth $2,893,000 after purchasing an additional 113,242 shares during the last quarter. Czech National Bank grew its stake in Walgreens Boots Alliance by 6.6% in the fourth quarter. Czech National Bank now owns 155,625 shares of the pharmacy operator's stock worth $1,452,000 after purchasing an additional 9,663 shares in the last quarter. Moody National Bank Trust Division increased its holdings in Walgreens Boots Alliance by 17.6% in the fourth quarter. Moody National Bank Trust Division now owns 32,026 shares of the pharmacy operator's stock valued at $299,000 after buying an additional 4,782 shares during the last quarter. First Financial Corp IN raised its stake in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after buying an additional 885 shares in the last quarter. Finally, SeaCrest Wealth Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $323,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.
Walgreens Boots Alliance Stock Performance
WBA traded down $0.02 during trading hours on Tuesday, hitting $11.24. The company's stock had a trading volume of 711,355 shares, compared to its average volume of 20,966,425. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.17. The company has a 50-day simple moving average of $11.03 and a 200 day simple moving average of $10.38. The firm has a market capitalization of $9.72 billion, a PE ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.77.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company's quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.20 earnings per share. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, May 13th. They issued a "hold" rating on the stock. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $10.59.
Read Our Latest Analysis on Walgreens Boots Alliance
Insider Buying and Selling
In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the business's stock in a transaction that occurred on Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 17.50% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.